Akums Drugs IPO review (Apply)
Review By Dilip Davda on July 26, 2024 • ADPL is a global player in CDMO and other pharma products with prime focus on India. • Its domestic market shares increased from 26.7% (FY21) to 30.2% (FY24). • Due to provisioning of Put Option calls from EBITDA, it posted poor bottom lines…